MAP 2.63% 18.5¢ microba life sciences limited

it depends on wha valuation model you use as to paying to much...

  1. 1,461 Posts.
    it depends on wha valuation model you use as to paying to much for an asset. Macquarie has a habit of using projected figures (and acurately) while most number crunchers will only use historical, and as a journalist who has to report you would say the futuristic thinkers seems to be over valuing an asset (by a factor of two) ... but when you bring a private asset into market cap its generally worth twice the amount
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.